Cancer Survival in Reunion Island , 1998-2008 (SUCRE)

Completed

• Conditions: Neoplasms

• Registration Number: NCT02900287
• Lead Sponsor: Centre Hospitalier Universitaire de la Réunion

Brief Summary

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Detailed Description

Data are extracted from Reunion Island Cancer Registry.

Study Timeline

• Study First Submitted: 2016-09-09
• Study First Submitted QC: 2016-09-13
• Study First Posted: 2016-09-14
• Study Start: 2019-01-01
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-04
• Last Update Posted: 2024-01-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18000

Inclusion Criteria

• Patients domiciled in Reunion Island at diagnosis
• Patients with at least 15 years of age at diagnosis
• Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

Exclusion Criteria

• Cutaneous malignant cancer expected melanoma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5 years related survival rate by cancer site and gender	5 years

Secondary Outcome Measures

Name	Time	Method
1, 3, 5 and 10 years related survival rate by cancer site and gender	1, 3, 5 and 10 years
1, 3, 5 and 10 years related survival rate by age at diagnosis	1, 3, 5 and 10 years
1, 3, 5 and 10 years standardised survival rate by cancer site and gender	1, 3, 5 and 10 years

Trial Locations

Locations (1)

CHU de La Réunion; 🇷🇪 Saint-Denis, Réunion